Cancer stem cells are supposed to be resistant to the various anti-cancer therapies and an obstacle against treatments, and stem cell biomarkers have been identified such as CD44, CD133, Ascl2, and Lgr5 in CRC [8–10]. The gene discussed is PROM1; the disease is colorectal carcinoma.